• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在多中心艾滋病队列研究中,大环内酯类药物的使用与感染HIV男性的血管疾病风险

Macrolide use and the risk of vascular disease in HIV-infected men in the Multicenter AIDS Cohort Study.

作者信息

Woolley Ian J, Li Xiuhong, Jacobson Lisa P, Palella Frank J, Ostergaard Lars

机构信息

Infectious Diseases Department, Alfred Hospital, Monash University Medical School, Prahran 3004, Victoria, Australia.

出版信息

Sex Health. 2007 Jun;4(2):111-9. doi: 10.1071/sh06052.

DOI:10.1071/sh06052
PMID:17524289
Abstract

BACKGROUND

There has been increasing concern that HIV-infected individuals may be more at risk for cardiovascular events in the highly-active antiretroviral therapy (HAART) era. This study examined the risk of thromboembolic events in HIV-infected and non-infected individuals and the effect of macrolide prophylaxis on those outcomes.

METHODS

A subcohort analysis was undertaken using data collected in the Multicenter AIDS Cohort Study to examine the relative risk of vascular events (myocardial infarction, unstable angina and ischaemic stroke). Cox proportional hazard model using age as the time scale with time varying cofactors obtained at each semi-annual visit were used to assess the independent effect of macrolide use.

RESULTS

Controlling for other significant effects including race and smoking, HIV-infection was not independently associated with vascular events. Increased risk was observed among those who used HAART (relative hazard 1.09, 95% confidence intervals 1.00-1.19 in multivariate model), antihypertensive treatment (1.81 [1.26-2.60]), lipid-lowering medication (1.65 [1.12-2.42]), and antibiotics (1.72 [1.25-2.36]). The protective association of macrolide use for a vascular event in the HAART era was also significant (0.10 [0.01-0.75]).

CONCLUSIONS

Traditional risk factors are important in the pathogenesis of vascular events in HIV-infected individuals. Macrolide antibiotics may have a protective effect in the HIV-infected individuals in the HAART era.

摘要

背景

在高效抗逆转录病毒治疗(HAART)时代,人们越来越担心感染人类免疫缺陷病毒(HIV)的个体发生心血管事件的风险可能更高。本研究调查了HIV感染个体和未感染个体发生血栓栓塞事件的风险,以及大环内酯类药物预防对这些结果的影响。

方法

使用多中心艾滋病队列研究收集的数据进行亚队列分析,以检查血管事件(心肌梗死、不稳定型心绞痛和缺血性中风)的相对风险。使用以年龄为时间尺度的Cox比例风险模型,结合每半年随访时获得的随时间变化的协变量,来评估使用大环内酯类药物的独立效应。

结果

在控制了包括种族和吸烟等其他显著影响因素后,HIV感染与血管事件并无独立关联。在使用HAART的人群(多变量模型中相对风险为1.09,95%置信区间为1.00-1.19)、接受抗高血压治疗的人群(1.81 [1.26-2.60])、接受降脂药物治疗的人群(1.65 [1.12-2.42])以及使用抗生素的人群(1.72 [1.25-2.36])中,观察到风险增加。在HAART时代,使用大环内酯类药物对血管事件的保护关联也很显著(0.10 [0.01-0.75])。

结论

传统风险因素在HIV感染个体血管事件的发病机制中很重要。在HAART时代,大环内酯类抗生素可能对HIV感染个体具有保护作用。

相似文献

1
Macrolide use and the risk of vascular disease in HIV-infected men in the Multicenter AIDS Cohort Study.在多中心艾滋病队列研究中,大环内酯类药物的使用与感染HIV男性的血管疾病风险
Sex Health. 2007 Jun;4(2):111-9. doi: 10.1071/sh06052.
2
Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.接受高效抗逆转录病毒治疗的HIV-1感染患者的脑血管缺血事件:发病率及危险因素
Cerebrovasc Dis. 2009;27(6):559-63. doi: 10.1159/000214219. Epub 2009 Apr 24.
3
Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.巴西HIV队列中抗逆转录病毒治疗及最低点CD4细胞计数对心血管事件进展及相关合并症的影响:一种多阶段方法
AIDS Care. 2018 May;30(5):551-559. doi: 10.1080/09540121.2017.1391984. Epub 2017 Oct 23.
4
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代城市中感染艾滋病毒及有吸毒风险人群队列中的死亡率
Clin Infect Dis. 2005 Sep 15;41(6):864-72. doi: 10.1086/432883. Epub 2005 Aug 16.
5
Hypertension Risk with Abacavir Use among HIV-Infected Individuals: A Nationwide Cohort Study.感染人类免疫缺陷病毒个体使用阿巴卡韦后的高血压风险:一项全国性队列研究
Yonsei Med J. 2018 Dec;59(10):1245-1252. doi: 10.3349/ymj.2018.59.10.1245.
6
Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS.高效抗逆转录病毒治疗与 HIV/AIDS 患者结核病发病的关联。
Ann Epidemiol. 2018 Dec;28(12):886-892.e3. doi: 10.1016/j.annepidem.2018.03.011. Epub 2018 Mar 28.
7
[Cardiovascular risk factors associated with antiretroviral therapy].[与抗逆转录病毒疗法相关的心血管危险因素]
Enferm Infecc Microbiol Clin. 2009 Sep;27 Suppl 1:24-32. doi: 10.1016/S0213-005X(09)73442-1.
8
The risk of myocardial infarction in HIV-infected patients receiving HAART: a case report.
Int J STD AIDS. 2001 Sep;12(9):612-3. doi: 10.1258/0956462011923660.
9
["HAART-attack" in young female HIV-patient].年轻女性艾滋病患者中的“高效抗逆转录病毒治疗攻击”
Internist (Berl). 2006 Sep;47(9):939-40, 942-3. doi: 10.1007/s00108-006-1679-7.
10
Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.高效抗逆转录病毒治疗时代阿巴卡韦的使用与急性心肌梗死和脑血管事件风险。
Clin Infect Dis. 2011 Jul 1;53(1):84-91. doi: 10.1093/cid/cir269.

引用本文的文献

1
Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis.大环内酯类药物心血管风险的管理:系统评价与荟萃分析
Drug Saf. 2017 Aug;40(8):663-677. doi: 10.1007/s40264-017-0533-2.